This Article Full Text Full Text (PDF) All Versions of this Article: 112/3/396    most recent CIRCULATIONAHA.104.529941v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Spuentrup, E. Articles by Buecker, A. Search for Related Content PubMed PubMed Citation Articles by Spuentrup, E. Articles by Buecker, A. Related Collections Arterial thrombosis Cardiovascular imaging agents/Techniques CT and MRI Embolic stroke Imaging

(Circulation. 2005;112:396-399.)
© 2005 American Heart Association, Inc.

Imaging

Molecular Magnetic Resonance Imaging of Atrial Clots in a Swine Model

Elmar Spuentrup, MD; Bernd Fausten, MD; Sylvia Kinzel, VD; Andrea J. Wiethoff, PhD; Rene M. Botnar, PhD; Philip B. Graham, PhD; Stephan Haller, MD; Marcus Katoh, MD; Edward C. Parsons, Jr, PhD; Warren J. Manning, MD; Thomas Busch, MD; Rolf W. Günther, MD; Arno Buecker, MD

From the Departments of Diagnostic Radiology (E.S., S.H., M.K., R.W.G., A.B.), Thoracic and Cardiovascular Surgery (B.F., T.B.), and Laboratory Animal Science (S.K.), Aachen Technical University, Aachen, Germany; EPIX Pharmaceuticals (A.J.W., P.B.G., E.C.P.), Cambridge, Mass; and the Departments of Medicine, Cardiovascular Division (R.M.B., W.J.M.), and Radiology (W.J.M.), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass.

Reprint requests to Elmar Spuentrup, MD, Department of Diagnostic Radiology, University Hospital, Aachen Technical University, Pauwelsstrasse 30, 52057 Aachen, Germany. E-mail spuenti{at}rad.rwth-aachen.de

Received December 17, 2004; revision received March 2, 2005; accepted March 8, 2005.

Background— The detection and differentiation of intracardiac masses is still challenging and may include neoplasms and thrombi. The aim of this study was the investigation of a targeted, fibrin-specific contrast agent (EP-2104R) for molecular targeted magnetic resonance imaging (MRI) of left atrial clots.

Methods and Results— Chronic human thrombi were surgically implanted in the left atrial appendage of 5 swine. Molecular MRI was performed with a navigator-gated, free-breathing, cardiac-triggered 3D inversion-recovery, black-blood, gradient-echo sequence before and after systemic administration of 4 µmol/kg EP-2104R. MR images were analyzed by 2 investigators, and the contrast-to-noise ratio was calculated. Location of clots was confirmed by autopsy, and the gadolinium concentration in the clots was assessed. Before contrast agent administration, thrombi were not visible on black-blood MR images. After contrast administration, all atrial clots (n=5) were selectively visualized as white spots with a high contrast-to-noise ratio (clot/blood, 29.7±8.0). The gadolinium concentration in the clots averaged 74±45 µmol/L.

Conclusions— The fibrin-specific MR contrast agent EP-2104R allows for selective and high-contrast visualization of left atrial clots by means of molecular targeted MRI.

Key Words: arrhythmia • atrium • imaging • fibrin • thrombus

This article has been cited by other articles:

				F. A. Jaffer, P. Libby, and R. Weissleder Molecular Imaging of Cardiovascular Disease Circulation, August 28, 2007; 116(9): 1052 - 1061. [Full Text] [PDF]

				M. A. Borger, P. M. Murphy, A. Alam, S. Fazel, M. Maganti, S. Armstrong, V. Rao, and T. E. David Initial results of the chordal-cutting operation for ischemic mitral regurgitation J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1483 - 1492. [Abstract] [Full Text] [PDF]

				C. P. Stracke, M. Katoh, A. J. Wiethoff, E. C. Parsons, P. Spangenberg, and E. Spuntrup Molecular MRI of Cerebral Venous Sinus Thrombosis Using a New Fibrin-Specific MR Contrast Agent Stroke, May 1, 2007; 38(5): 1476 - 1481. [Abstract] [Full Text] [PDF]

				S. A. Wickline, A. M. Neubauer, P. Winter, S. Caruthers, and G. Lanza Applications of Nanotechnology to Atherosclerosis, Thrombosis, and Vascular Biology Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 435 - 441. [Abstract] [Full Text] [PDF]